Fundraising Fox

Biotech Investors & VC Firms in Hong Kong

36 firms in this list, with a median first check of $1.2M. 3 of them lead rounds. Generated from verified public data and updated continuously.

Y Combinator
San FranciscoPre-Seed–Series A$500K
22 people
Capria Ventures
BengaluruSeed–Late Stage$300K – $1M
87 people
IMM Investment Japan
SeoulSeed–Late Stage
21 people
Gobi Partners
Hong KongPre-Seed–Late Stage$709K – $37M
74 people
Impact Fund Denmark
CopenhagenSeed–Late Stage$2.2M – $70.2M
36 people
K3 Ventures
SingaporeSeed–Growth$1.2M – $42M
23 people
Panacea Venture
SingaporePre-Seed–Late Stage
20 people
Beyond Ventures
Hong KongSeed–Growth$720K – $138M
16 people
Saltagen Ventures
Hong KongSeed–Series B
21 people
LAV
Hong KongSeed–Series C$5M – $15M
3 people
Blue Ocean Capital Group
ShenzhenLate Stage
21 people
SAV (Scale Asia Ventures)
Palo AltoSeed–Series B
12 people
Lilly Asia Ventures
Hong KongPre-Seed–Late Stage
1 person
CITIC Capital Holdings
Hong KongGrowth–Late Stage
21 people
Cowin Capital Group
ShenzhenSeed–Late Stage$1.4M – $50M
11 people
Intermediate Capital Group
LondonGrowth–Late Stage$5M – $50M
16 people
Vertex Venture Management Pte. Ltd.
SingaporePre-Seed–Growth
16 people
Widus Partners
Seoul
HongShan Capital Group
Hong KongPre-Seed–Late Stage
Soul Ventures
Series C–Late Stage
12 people
IDG Capital
Hong KongPre-Seed–Late Stage$3M – $200M
5 people
NewMargin Ventures
ShanghaiPre-Seed–Late Stage$425K – $200M
5 people
AEF Greater Bay Area Fund
Hong KongSeed–Series B$2.5M – $28M
SEEDS Capital
SingaporePre-Seed–Series B$250K – $9M

Related lists

Data sourced from public filings and firms' own websites — see our methodology.